Chemotherapeutic agents for cancer
Cardiomyopathy - Chemotherapeutic agents for cancer Factor
Last reviewed for CCPS 18 July 2007.
Preliminary questions [38000]
38001 there is some evidence that treatment with chemotherapeutic agents for cancer may be a factor in the development or worsening of the condition under consideration.
38002 the veteran has been treated with chemotherapeutic agents for cancer at some time.
38003 — the cancer, for which the veteran was treated with chemotherapeutic agents, is an illness or injury which is identifiable.
38006 — the veteran has established the causal connection between treatment with chemotherapeutic agents for cancer and VEA service for cardiomyopathy.
38004 the identified illness or injury, a cancer, was treated with chemotherapeutic agents within the 30 days before the clinical onset of the condition under consideration.
38007 — the veteran has established the causal connection between treatment with chemotherapeutic agents for cancer and VEA service for the clinical onset of cardiomyopathy.
38009 — the veteran has established the causal connection between treatment with chemotherapeutic agents for cancer and operational service for the clinical onset of cardiomyopathy.
or
38010 — the veteran has established the causal connection between treatment with chemotherapeutic agents for cancer and eligible service for the clinical onset of cardiomyopathy.
or
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened. the identified illness or injury, a cancer, was treated with chemotherapeutic agents within the 30 days before the clinical worsening of the condition under consideration.38008 — the veteran has established the causal connection between treatment with chemotherapeutic agents for cancer and VEA service for the clinical worsening of cardiomyopathy.
38011 — the veteran has established the causal connection between treatment with chemotherapeutic agents for cancer and operational service for the clinical worsening of cardiomyopathy.
or
38012 — the veteran has established the causal connection between treatment with chemotherapeutic agents for cancer and eligible service for the clinical worsening of cardiomyopathy.
Clinical onset and operational service [38009]
38013 — the identified illness or injury, a cancer which was treated with chemotherapeutic agents, is causally related to operational service.
Clinical onset and eligible service [38010]
38014 — the identified illness or injury, a cancer which was treated with chemotherapeutic agents, is causally related to eligible service.
Clinical worsening and operational service [38011]
38013 — the identified illness or injury, a cancer which was treated with chemotherapeutic agents, is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, a cancer which was treated with chemotherapeutic agents, is causally related.Clinical worsening and eligible service [38012]
38014 — the identified illness or injury, a cancer which was treated with chemotherapeutic agents, is causally related to eligible service.
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, a cancer which was treated with chemotherapeutic agents, is causally related.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/c-d/cardiomyopathy-g021-4254-425964866748/rulebase-cardiomyopathy/chemotherapeutic-agents-cancer